Barbara Klencke's Net Worth

$643 Thousand

Estimate Recalculated Sep 9, 2024 12:20AM EST

Who is Barbara Klencke

Barbara Klencke does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., eFFECTOR Therapeutics, Inc., TScan Therapeutics, Inc., and Xencor Inc.

SEC CIK

Barbara Klencke's CIK is 0001647647

Past Insider Trading and Trends

2024 was Barbara Klencke's most active year for acquiring shares with 7 total transactions. Barbara Klencke's most active month to acquire stocks was the month of May. 2022 was Barbara Klencke's most active year for disposing of shares, totalling 11 transactions. Barbara Klencke's most active month to dispose stocks was the month of June. 2020 saw Barbara Klencke paying a total of $72,709.60 for 173,041 shares, this is the most they've acquired in one year. In 2022 Barbara Klencke cashed out on 342,551 shares for a total of $550,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sierra Oncology, Inc.

Chief Medical Officer
Updated Jul 01, 2022
Jul 01
12.25KJun 17
50.00KMar 14
12.25KJan 28
30.00KMar 15
Aug 18
167.09KFeb 25
Aug 22 - Aug 23
200.00KMar 04
180.36KMar 06
70.00KMar 06
456.00KSep 30
82.50KMar 08
Showing 14 results

eFFECTOR Therapeutics, Inc.

Investor
Updated Jun 13, 2024
800.00Jun 13
2.00KFeb 19
20.00KJun 22
28.13KJan 20
20.00KJun 09
40.00KNov 01
Showing 7 results

TScan Therapeutics, Inc.

Investor
Updated Aug 27, 2024
Aug 23 - Aug 26
47.50KJun 12
Dec 14
36.52KJun 13
9.15KApr 06
50.00K
Showing 6 results

Xencor Inc

Investor
Updated Jun 17, 2024
17.96KJun 13
40.07KSep 15
Showing 3 results